SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000944809-18-000050
Filing Date
2018-11-09
Accepted
2018-11-09 16:07:43
Documents
5
Period of Report
2018-11-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8-kearningsq3201811x9x18.htm 8-K 47890
2 EXHIBIT 99.1 ex991-pressrelease11x8x18.htm EX-99.1 124508
3 EXHIBIT 99.2 ex992-pressrelease11x8x18.htm EX-99.2 8632
4 ex991pressrelease1181_image1.gif GRAPHIC 2890
5 ex992pressrelease1181_image1.gif GRAPHIC 6163
  Complete submission text file 0000944809-18-000050.txt   195478
Mailing Address 4400 BISCAYNE BLVD. MIAMI FL 33137
Business Address 4400 BISCAYNE BLVD. MIAMI FL 33137 305-575-4138
Opko Health, Inc. (Filer) CIK: 0000944809 (see all company filings)

IRS No.: 752402409 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33528 | Film No.: 181173156
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1